Menu
close
Please contact us for more information or to learn if you are eligible to participate.
The purpose of this study is to evaluate the growth and tolerance of preterm infants fed a next generation Similac HMF, compared to the current standard of care of Similac HMF.
Principal Investigator | Dynio Honrubia, MD |
Co-PI | Luis Cantu Jr. |
Sponsor | Abbott Nutrition |
Type of Trial | Interventional |